Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar 20:7:305-13.
doi: 10.2147/IJWH.S68979. eCollection 2015.

Vulvar cancer: epidemiology, clinical presentation, and management options

Affiliations
Review

Vulvar cancer: epidemiology, clinical presentation, and management options

Ibrahim Alkatout et al. Int J Womens Health. .

Abstract

Epidemiology: Vulvar cancer can be classified into two groups according to predisposing factors: the first type correlates with a HPV infection and occurs mostly in younger patients. The second group is not HPV associated and occurs often in elderly women without neoplastic epithelial disorders.

Histology: Squamous cell carcinoma (SCC) is the most common malignant tumor of the vulva (95%).

Clinical features: Pruritus is the most common and long-lasting reported symptom of vulvar cancer, followed by vulvar bleeding, discharge, dysuria, and pain.

Therapy: The gold standard for even a small invasive carcinoma of the vulva was historically radical vulvectomy with removal of the tumor with a wide margin followed by an en bloc resection of the inguinal and often the pelvic lymph nodes. Currently, a more individualized and less radical treatment is suggested: a radical wide local excision is possible in the case of localized lesions (T1). A sentinel lymph node (SLN) biopsy may be performed to reduce wound complications and lymphedema.

Prognosis: The survival of patients with vulvar cancer is good when convenient therapy is arranged quickly after initial diagnosis. Inguinal and/or femoral node involvement is the most significant prognostic factor for survival.

Keywords: HPV infection; groin dissection; overall survival; radical vulvectomy; sentinel lymph node biopsy; vulvar cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lymphatic drainage of the vulva.
Figure 2
Figure 2
Keratinizing squamous cell carcinoma of the vulva (Hematoxylin and eosin stain, ×5).
Figure 3
Figure 3
Elastica van Giesson stained (5× magnification) pT1G2 vulvar carcinoma.
Figure 4
Figure 4
Transition from normal epithelia to squamous cell carcinoma of the vulva (Hematoxylin and eosin stain, ×5).
Figure 5
Figure 5
Standard of LNE in patients with vulvar cancer. Abbreviations: LNE, lymphonodectomy; SLN, sentinel lymph node.

Similar articles

Cited by

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. - PubMed
    1. Hunter DJ. Carcinoma of the vulva: a review of 361 patients. Gynecol Oncol. 1975;3(2):117–123. - PubMed
    1. Gunther V, Alkatout I, Lez C, et al. Malignant melanoma of the urethra: a rare histologic subdivision of vulvar cancer with a poor prognosis. Case Rep Obstet Gynecol. 2012;2012:385175. - PMC - PubMed
    1. Way S. The anatomy of the lymphatic drainage of the vulva and its influence on the radical operation for carcinoma. Ann R Coll Surg Engl. 1948;3(4):187–209. - PMC - PubMed
    1. Horn LC, Klostermann K, Hautmann S, Höhn AK, Beckmann MW, Mehlhorn G. HPV-assoziierte Veränderungen an Vulva und Vagina [HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology] Pathologe. 2011;32(6):467–475. German. - PubMed